SFX by Ex Libris Inc.

Title:	Screening hCHK2 for mutations
Source:	Science [0036-8075] Sodha, N yr:2000

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	KOOI, CF. "Salt gradient solar pond with reflective bottom- Application to the'saturated' pond." Solar energy 26.2 (1981): 113-.
description	2.	Murday, H. "Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations." Nature genetics 31.1: 55-59.
description	3.	Vahteristo, P. "A CHEK 2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer." American Journal of Human Genetics 71.2 (2002): 432-438.
description	4.	Bell, D W W. "Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome." Science 286.5449: 2528-2531.
description	5.	Ying Huang Mark A Bayfield Robert V Intine Richard, Richard J J. "Separate RNA-binding surfaces on the multifunctional La protein mediate distinguishable activities in tRNA maturation." Nature structural & molecular biology 13.7: 611-618.
description	6.	Hunter, David J J. "A genome - wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer." Nature genetics 39.7 (2007): 870-4.
description	7.	Bhattarai, A. "Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar." PLoS medicine 4.11 (2007): 1784-1790.
description	8.	Bojesen, M. "Genome-wide association study identifies novel breast cancer susceptibility loci." Nature 447.7148 (2007): 1087-93.
description	9.	Stacey, Simon N., Simon N N. "Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer." Nature genetics 39.7 (2007): 865-869.
description	10.	Hunter, David J. "A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)." Nature Genetics 41.5 (2009): 579-84.
description	11.	Desai, Edison V. "Initiating oncogenic event determines gene-expression patterns of human breast cancer models." Proceedings of the National Academy of Sciences of the United States of America 99.10 (2002): 6967-6972.
description	12.	Renwick, A. "ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles." Nature genetics 38.8 (2006): 873-5.
description	13.	Winqvist, R. "RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability." Carcinogenesis 27.8: 1593-9.
description	14.	Cuzick, J. "Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial." Journal of the National Cancer Institute 99.4 (2007): 272-82.
description	15.	Hayes, N. "Genome-wide association study of prostate cancer identifies a second risk locus at 8q24." Nature genetics 39.5 (2007): 645-649.
description	16.	Vahteristo, P. "p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition." Cancer research 61.15 (2001): 5718-22.
description	17.	Sodha, N. "Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome." Human mutation 20.6 (2002): 460-462.
description	18.	Malkin, D. "Correction: a Li-Fraumeni syndrome p53 mutation." Science 259.5097 (1993): 878-.
description	19.	Ashkar, S. "Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity." Science 287.5454 (2000): 860-4.
description	20.	Srivastava, S. "Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome." Nature 348.6303 (1990): 747-9.